(Q33823393)

29 July 2017

1 reference

title

Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapies (English)

1 reference

29 July 2017

1 reference

Langley PC

1

1 reference

PubMed ID

10645759

29 July 2017

Richwald GA

series ordinal

2

1 reference

PubMed ID

10645759

29 July 2017

Smith MH

series ordinal

3

1 reference

29 July 2017

1 December 1999

1 reference

29 July 2017

Clinical Therapeutics

1 reference

29 July 2017

21

1 reference

29 July 2017

12

1 reference

29 July 2017

2143-2155

1 reference

Epidemiology of Genital Human Papillomavirus Infection

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

7 January 2021

External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

7 January 2021

Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

7 January 2021

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

7 January 2021

The cost of treating genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2987244-6

1 reference

7 January 2021

10.1016/S0149-2918(00)87244-6

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10645759